Cargando…
Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy
For the optimal management of refractory ulcerative colitis (UC), secondary loss of response (LOR) and primary non-response to biologics is a critical issue. This article aimed to summarize the current literature on the use of cytapheresis (CAP) in patients with UC showing a poor response or LOR to...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494931/ https://www.ncbi.nlm.nih.gov/pubmed/36160647 http://dx.doi.org/10.3748/wjg.v28.i34.4959 |